Hinchliffe Jonathan David, Parassini Madappura Alakananda, Syed Mohamed Syed Mohammad Daniel, Roy Ipsita
Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield S1 3JD, UK.
Polymers (Basel). 2021 Mar 29;13(7):1081. doi: 10.3390/polym13071081.
Plastics have found widespread use in the fields of cosmetic, engineering, and medical sciences due to their wide-ranging mechanical and physical properties, as well as suitability in biomedical applications. However, in the light of the environmental cost of further upscaling current methods of synthesizing many plastics, work has recently focused on the manufacture of these polymers using biological methods (often bacterial fermentation), which brings with them the advantages of both low temperature synthesis and a reduced reliance on potentially toxic and non-eco-friendly compounds. This can be seen as a boon in the biomaterials industry, where there is a need for highly bespoke, biocompatible, processable polymers with unique biological properties, for the regeneration and replacement of a large number of tissue types, following disease. However, barriers still remain to the mass-production of some of these polymers, necessitating new research. This review attempts a critical analysis of the contemporary literature concerning the use of a number of bacteria-derived polymers in the context of biomedical applications, including the biosynthetic pathways and organisms involved, as well as the challenges surrounding their mass production. This review will also consider the unique properties of these bacteria-derived polymers, contributing to bioactivity, including antibacterial properties, oxygen permittivity, and properties pertaining to cell adhesion, proliferation, and differentiation. Finally, the review will select notable examples in literature to indicate future directions, should the aforementioned barriers be addressed, as well as improvements to current bacterial fermentation methods that could help to address these barriers.
由于具有广泛的机械和物理特性,以及在生物医学应用中的适用性,塑料在化妆品、工程和医学科学领域得到了广泛应用。然而,鉴于进一步扩大目前许多塑料合成方法的环境成本,最近的工作重点是使用生物方法(通常是细菌发酵)制造这些聚合物,这带来了低温合成以及减少对潜在有毒和不环保化合物依赖的优点。这在生物材料行业中可被视为一件好事,因为在疾病发生后,需要高度定制、生物相容、可加工且具有独特生物学特性的聚合物来再生和替代大量组织类型。然而,这些聚合物中的一些在大规模生产方面仍然存在障碍,因此需要进行新的研究。本综述试图对当代文献进行批判性分析,内容涉及在生物医学应用背景下使用多种细菌衍生聚合物的情况,包括所涉及的生物合成途径和生物体,以及围绕其大规模生产的挑战。本综述还将考虑这些细菌衍生聚合物有助于生物活性的独特特性,包括抗菌特性、氧气渗透性以及与细胞粘附、增殖和分化相关的特性。最后,本综述将选择文献中的显著例子,以指明如果上述障碍得到解决后的未来方向,以及对当前细菌发酵方法的改进,这些改进有助于解决这些障碍。